Avri Havron
Director/Board Member at Active P Ltd.
Net worth: 244 174 $ as of 2024-05-30
Network origin in Avri Havron first degree
Entity | Entity type | Industry | |
---|---|---|---|
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel.
2
| Private Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Avri Havron via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
SAFETEK INTERNATIONAL, INC. | Financial Conglomerates | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree | |
Technion Institute | College/University | Masters Business Admin | |
Biorest Ltd. | Corporate Officer/Principal | ||
Scigen (I.L.) Ltd.
Scigen (I.L.) Ltd. Pharmaceuticals: MajorHealth Technology Part of FDS Pharma LLP, Scigen (I.L.) Ltd. is an Israeli company that manufactures vaccines. The company is based in Rehovot, Israel. The CEO of the company is Yehuda Zelig. Scigen (I.L. was acquired by FDS Pharma LLP from SciGen Pte Ltd. on February 14, 2012 for $2 million. | Pharmaceuticals: Major | Chief Executive Officer | |
SCISPARC LTD. | Pharmaceuticals: Major | Director/Board Member | |
Accellta Ltd.
Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Biotechnology | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
QuantomiX Ltd.
QuantomiX Ltd. Pharmaceuticals: MajorHealth Technology QuantomiX Ltd. develops and markets capsules that enable real-time analysis of wet cells and tissue biopsies. The firm with the its QXTM capsule product line, wet samples, including cells and tissues biopsies, will be able to be examined immediately and accurately. The company's technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. QuantomiX was founded in March 2001 by Micha Brunstein, Zachy Berger and Ory S. Zik and is headquartered in Rehovot, Israel. | Pharmaceuticals: Major | Director/Board Member | |
SOLEGREEN | Alternative Power Generation | Director/Board Member | |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Corporate Officer/Principal | |
Avraham Pharmaceuticals Ltd.
Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Biotechnology | Director/Board Member | |
Valin Technologies Ltd. | Founder |
Statistics
International
Israel | 13 |
United States | 4 |
United Kingdom | 2 |
Romania | 2 |
Sectoral
Health Technology | 10 |
Consumer Services | 5 |
Finance | 2 |
Utilities | 2 |
Operational
Director/Board Member | 10 |
Corporate Officer/Principal | 4 |
Chairman | 1 |
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Yigal Koltin | 11 |
Yehuda Zelig | 8 |
- Stock Market
- Insiders
- Avri Havron
- Company connections